| Year |
Citation |
Score |
| 2025 |
Plummer R, Sodergren MH, Hodgson R, Ryan BM, Raulf N, Nicholls JP, Reebye V, Voutila J, Sinigaglia L, Meyer T, Pinato DJ, Sarker D, Basu B, Blagden S, Cook N, et al. TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors. Cell Reports. Medicine. 102041. PMID 40168999 DOI: 10.1016/j.xcrm.2025.102041 |
0.371 |
|
| 2024 |
Deobagkar-Lele M, Crawford G, Crockford TL, Back J, Hodgson R, Bhandari A, Bull KR, Cornall RJ. B cells require DOCK8 to elicit and integrate T cell help when antigen is limiting. Science Immunology. 9: eadd4874. PMID 39121196 DOI: 10.1126/sciimmunol.add4874 |
0.588 |
|
| 2023 |
Hodgson R, Crockford TL, Bhandari A, Kepple JD, Back J, Cawthorne E, Abeler-Dörner L, Laing AG, Clare S, Speak A, Adams DJ, Dougan G, Hayday AC, Deobagkar-Lele M, Cornall RJ, et al. Prolidase Deficiency Causes Spontaneous T Cell Activation and Lupus-Like Autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 36637239 DOI: 10.4049/jimmunol.2200212 |
0.57 |
|
| 2022 |
Hodgson R, Xu X, Anzilotti C, Deobagkar-Lele M, Crockford TL, Kepple JD, Cawthorne E, Bhandari A, Cebrian-Serrano A, Wilcock MJ, Davies B, Cornall RJ, Bull KR. NDRG1 is induced by antigen-receptor signaling but dispensable for B and T cell self-tolerance. Communications Biology. 5: 1216. PMID 36357486 DOI: 10.1038/s42003-022-04118-w |
0.592 |
|
| Show low-probability matches. |